Korrektur
Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”
Cancer · 15.11.2026 · 132 (22)
DOI: 10.1002/cncr.70667 ↗Kurz gefasst
Korrektur in der Zeitschrift Cancer, online erschienen am 06.11.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”. Cancer, 132(22). https://doi.org/10.1002/cncr.70667
Vancouver
Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”. Cancer. 2026;132(22). doi:10.1002/cncr.70667
BibTeX
@article{euvimed2026,
title = {Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”},
journal = {Cancer},
year = {2026},
volume = {132},
number = {22},
doi = {10.1002/cncr.70667}
}
EUVIMED